“Precision Oncology: Changing the Game for Metastatic Liver Cancer” to air Sunday, November 15 at 5:30 p.m. ET / 2:30 pm PT ...

Juniper Biosciences ("Juniper" or "the Company"), a radiopharmaceutical drug development company, today announced the ...

Cumulative prescribers reached 2,410, exceeding the Company’s original full-year 2026 goal of approximately 2,000 a quarter ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

At the same time, Jason Duncan brings to us a rare combination of legal, governance and operational experience helping scale ...

Wednesday, December 2 at 9:00 a.m. ET Live and archived webcasts of the presentations will be available on the “Events” ...

Nearly three times as many patients taking Taltz and Zepbound achieved ≥50% reduction in psoriatic arthritis disease activity ...

Top-line results for SLIM-1™, the first-in-human Phase 1 trial of NPM-139, Vivani's miniature, ultra-long-acting semaglutide ...

Skribe Medical, a U.S. medical technology company developing wearable cardiac monitoring for cancer care, today announced ...

Real-world analysis of more than 294,000 U.S. Veterans aged 65 and older found mNEXSPIKE was associated with a 35.9% lower ...

The pattern the team uncovered adds to growing evidence that the fluid could stand in for a tissue sample when assessing ...

Transformative Biotech, LLC (T-Bio), a molecular diagnostics company, announced today that Nicholas Meyerson, PhD, has joined ...